Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration

Robert Langenbach, Scott G. Morham, Howard F. Tiano, Charles D. Loftin, Burhan I. Ghanayem, Patricia C. Chulada, Joel F. Mahler, Christopher A. Lee, Eugenia H. Goulding, Kimberly D. Kluckman, H. S. Kim, Oliver Smithies

Research output: Contribution to journalArticlepeer-review

1063 Scopus citations

Abstract

Cyclooxygenases 1 and 2 (COX-1 and COX-2) are key enzymes in prostaglandin biosynthesis and the target enzymes for the widely used nonsteroidal anti-inflammatory drugs. To study the physiological roles of the individual isoforms, we have disrupted the mouse Ptgs1 gene encoding COX-1. Homozygous Ptgs1 mutant mice survive well, have no gastric pathology, and show less indomethacin-induced gastric ulceration than wild-type mice, even though their gastric prostaglandin E2 levels are about 1% of wild type. The homozygous mutant mice have reduced platelet aggregation and a decreased inflammatory response to arachidonic acid, but not to tetradecanoyl phorbol acetate. Ptgs1 homozygous mutant females mated to homozygous mutant males produce few live offspring. COX-1-deficient mice provide a useful model to distinguish the physiological roles of COX-1 and COX-2.

Original languageEnglish
Pages (from-to)483-492
Number of pages10
JournalCell
Volume83
Issue number3
DOIs
StatePublished - Nov 3 1995

Bibliographical note

Funding Information:
Correspondence should be addressed to Ft. L. The authors are grateful to Dr. L. Marnett for his constructive comments on the manuscript and thank Drs. J. Krege and T. Eling for critically reading the manuscript. The authors thank Dr. D. Dewitt for supplying the antibody to COX-1. We appreciate the fine efforts of R. Ingram and the Comparative Medicine Branch for animal care, T. McIntyre for assistance in the NSAID studies, and 6. Gaul for the necropsy work, as well as the National Institute of Environmental Health Sciences histology laboratory for preparation of tissues. 0. S. is supported by National Institutes of Health grants GM20069 and HL49227. S. G. M. is an American Cancer Society fellow (#PF-3973).

Funding

Correspondence should be addressed to Ft. L. The authors are grateful to Dr. L. Marnett for his constructive comments on the manuscript and thank Drs. J. Krege and T. Eling for critically reading the manuscript. The authors thank Dr. D. Dewitt for supplying the antibody to COX-1. We appreciate the fine efforts of R. Ingram and the Comparative Medicine Branch for animal care, T. McIntyre for assistance in the NSAID studies, and 6. Gaul for the necropsy work, as well as the National Institute of Environmental Health Sciences histology laboratory for preparation of tissues. 0. S. is supported by National Institutes of Health grants GM20069 and HL49227. S. G. M. is an American Cancer Society fellow (#PF-3973).

FundersFunder number
National Institutes of Health (NIH)HL49227
National Institute of General Medical SciencesR01GM020069

    ASJC Scopus subject areas

    • General Biochemistry, Genetics and Molecular Biology

    Fingerprint

    Dive into the research topics of 'Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration'. Together they form a unique fingerprint.

    Cite this